Angpt2/Tie2 autostimulatory loop controls tumorigenesis.
PitNETs
angiopoietin 2
anti-angiopoietin biologicals
tumor-bound Tie2
tumor/endothelial cell crosstalk
Journal
EMBO molecular medicine
ISSN: 1757-4684
Titre abrégé: EMBO Mol Med
Pays: England
ID NLM: 101487380
Informations de publication
Date de publication:
09 05 2022
09 05 2022
Historique:
revised:
04
02
2022
received:
01
04
2021
accepted:
08
02
2022
pubmed:
11
3
2022
medline:
11
5
2022
entrez:
10
3
2022
Statut:
ppublish
Résumé
Invasive nonfunctioning (NF) pituitary neuroendocrine tumors (PitNETs) are non-resectable neoplasms associated with frequent relapses and significant comorbidities. As the current therapies of NF-PitNETs often fail, new therapeutic targets are needed. The observation that circulating angiopoietin-2 (ANGPT2) is elevated in patients with NF-PitNET and correlates with tumor aggressiveness prompted us to investigate the ANGPT2/TIE2 axis in NF-PitNETs in the GH3 PitNET cell line, primary human NF-PitNET cells, xenografts in zebrafish and mice, and in MENX rats, the only autochthonous NF-PitNET model. We show that PitNET cells express a functional TIE2 receptor and secrete bioactive ANGPT2, which promotes, besides angiogenesis, tumor cell growth in an autocrine and paracrine fashion. ANGPT2 stimulation of TIE2 in tumor cells activates downstream cell proliferation signals, as previously demonstrated in endothelial cells (ECs). Tie2 gene deletion blunts PitNETs growth in xenograft models, and pharmacological inhibition of Angpt2/Tie2 signaling antagonizes PitNETs in primary cell cultures, tumor xenografts in mice, and in MENX rats. Thus, the ANGPT2/TIE2 axis provides an exploitable therapeutic target in NF-PitNETs and possibly in other tumors expressing ANGPT2/TIE2. The ability of tumor cells to coopt angiogenic signals classically viewed as EC-specific expands our view on the microenvironmental cues that are essential for tumor progression.
Identifiants
pubmed: 35266635
doi: 10.15252/emmm.202114364
pmc: PMC9081903
doi:
Substances chimiques
ANGPT2 protein, human
0
Angiopoietin-2
0
Receptor, TIE-2
EC 2.7.10.1
TEK protein, human
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14364Informations de copyright
© 2022 The Authors. Published under the terms of the CC BY 4.0 license.
Références
Oncol Rep. 2004 Oct;12(4):849-53
pubmed: 15375511
Annu Rev Med. 1996;47:95-106
pubmed: 8712806
Br J Cancer. 2016 Apr 12;114(8):855-62
pubmed: 27031850
Oncotarget. 2018 Jan 9;9(16):12705-12717
pubmed: 29560103
Clin Cancer Res. 2010 Jan 15;16(2):420-9
pubmed: 20068079
J Neurooncol. 2017 Apr;132(2):199-206
pubmed: 28255749
EMBO Mol Med. 2022 May 9;14(5):e14364
pubmed: 35266635
Sci Rep. 2017 Dec 6;7(1):17038
pubmed: 29213099
Theranostics. 2018 Sep 09;8(17):4765-4780
pubmed: 30279736
Int J Gynecol Cancer. 2010 Dec;20(9):1498-505
pubmed: 21119365
Cell. 1996 Dec 27;87(7):1161-9
pubmed: 8980223
Circ Res. 1998 Oct 19;83(8):852-9
pubmed: 9776732
Endocr Relat Cancer. 2014 Jan 21;21(1):R67-83
pubmed: 24292602
Clin Cancer Res. 2015 Jul 15;21(14):3204-15
pubmed: 25838390
Acta Neuropathol. 2013 Jul;126(1):137-50
pubmed: 23756599
PLoS One. 2014 Mar 14;9(3):e91808
pubmed: 24632811
Proc Natl Acad Sci U S A. 2017 Apr 25;114(17):4376-4381
pubmed: 28396439
Eur J Endocrinol. 2016 Feb;174(2):137-45
pubmed: 26546611
Brain Tumor Pathol. 2018 Apr;35(2):51-56
pubmed: 29687298
Circ Res. 2000 Jan 7-21;86(1):24-9
pubmed: 10625301
Exp Cell Res. 2006 Mar 10;312(5):630-41
pubmed: 16225862
Br J Cancer. 2010 Oct 26;103(9):1407-14
pubmed: 20924372
Endocr Relat Cancer. 2015 Feb;22(1):111-9
pubmed: 25515731
Dev Dyn. 1995 Jul;203(3):253-310
pubmed: 8589427
Exp Cell Res. 2013 May 15;319(9):1271-80
pubmed: 23500414
Int J Cancer. 2003 Feb 10;103(4):466-74
pubmed: 12478661
Oncogene. 2000 Sep 14;19(39):4549-52
pubmed: 11002428
J Pathol. 2004 Sep;204(1):1-10
pubmed: 15307132
Clin Cancer Res. 2009 Feb 15;15(4):1384-92
pubmed: 19228739
Endocr Relat Cancer. 2017 Apr;24(4):C5-C8
pubmed: 28264912
J Neurosurg. 2015 Apr;122(4):803-11
pubmed: 25658782
Neuropathol Appl Neurobiol. 2013 Apr;39(3):256-69
pubmed: 22524684
J Biol Chem. 1999 Aug 20;274(34):24425-30
pubmed: 10446223
Nat Cell Biol. 2008 May;10(5):513-26
pubmed: 18425120
Pituitary. 2014 Jun;17(3):267-76
pubmed: 23828322
Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1635-45
pubmed: 16714355
Cancer Res. 2006 Jan 15;66(2):775-83
pubmed: 16424009
J Cell Sci. 2006 Sep 1;119(Pt 17):3551-60
pubmed: 16895971
Pituitary. 2018 Dec;21(6):593-604
pubmed: 30288666
Blood. 2004 Jun 1;103(11):4150-6
pubmed: 14976056
Circ Res. 2006 Apr 28;98(8):1014-23
pubmed: 16645151
Pituitary. 2018 Apr;21(2):203-207
pubmed: 29344906
Cancer Res. 2013 Jan 1;73(1):108-18
pubmed: 23149917